Menu
Log in


Member Log In

Innovation During COVID-19 Townhall: Progress Towards COVID-19 Therapeutics

  • 22 Jul 2020
  • 12:00 PM (CST)
  • Virtual

cid:image003.png@01D658F8.93E1C9B0

VIRTUAL

Innovation During COVID-19 Townhall:

Progress Towards COVID-19 Therapeutics

Wednesday, July 22nd, 2020

1:00 to 2:30 p.m. ET

America’s biopharmaceutical companies’ have acted quickly to focus their expertise on treatments for COVID-19. Currently, treatments being tested range from antiviral and antibody therapies to anticoagulant and antimicrobial therapies – to target both the virus itself and the most dangerous health consequences of COVID-19.

Please join PhRMA member company executives for a townhall on COVID-19 therapeutic development – a unique forum to hear directly from leaders in the fight to beat COVID-19, including:

Ramona Sequeira, President, Takeda

David Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company

Alexander Hardy, Chief Executive Officer, Genentech

Johanna Mercier, Chief Commercial Officer, Gilead

If you wish to submit a question for the panel, please use the registration link or emailphrma_alliance@phrma.org by close of business Friday, July 17th.

Please click here to RSVP to the event.

Dial-in information will be shared with those who RSVP on

Tuesday, July 21st.


Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
P.O. Box 583
Arab, AL 35016


administrator@bioalabama.com

© BIO Alabama

Powered by Wild Apricot Membership Software